We observed a significant increase in GRIA4 methylation in the plasma of metastatic patients, with a remarkable 16.4-fold amplification, which nominates this gene as potential novel biomarker for an early non-invasive detection of metastasis of clinically known CRC, however, additional analysis of a larger sample cohort must be performed. The gene discussed is GRIA4; the disease is colorectal carcinoma.